COMPARATIVE EFFICACY OF CHRONIC HEART FAILURE TREATMENT WITH PERINDOPRIL OR CARVEDILOL IN PATIENTS WITH ALCOHOLIC OR IDIOPATHIC DILATED CARDIOMYOPATHY

Aim. To study the clinical and hemodynamic efficacy of monotherapy with ACE inhibitor perindopril or beta-blocker carvedilol in patients with chronic heart failure (CHF) due to dilated cardiomyopathy (DCMP) of various etiology.<br />Material and methods. Patients (n=69) with DCMP of different...

Full description

Bibliographic Details
Main Authors: I. V. Zhirov, G. K. Sarbalinova, S. N. Tereschenko
Format: Article
Language:English
Published: Столичная издательская компания 2015-09-01
Series:Рациональная фармакотерапия в кардиологии
Subjects:
Online Access:http://www.rpcardio.ru/jour/article/view/271
_version_ 1797701870685257728
author I. V. Zhirov
G. K. Sarbalinova
S. N. Tereschenko
author_facet I. V. Zhirov
G. K. Sarbalinova
S. N. Tereschenko
author_sort I. V. Zhirov
collection DOAJ
description Aim. To study the clinical and hemodynamic efficacy of monotherapy with ACE inhibitor perindopril or beta-blocker carvedilol in patients with chronic heart failure (CHF) due to dilated cardiomyopathy (DCMP) of various etiology.<br />Material and methods. Patients (n=69) with DCMP of different etiology were included into the open randomized study. Idiopathic DCMP (IDCMP) was diagnosed in 26 patients and alcoholic cardiomyopathy (ACMP) - in 43 patients. Patients of IDCMP and ACMP groups were randomized for treatment with perindopril (groups 1 and 3, respectively) or carvedilol (groups 2 and 4, respectively). Follow-up was 6 months. End-diastolic and end-systolic left ventricular volume, stroke volume index, ejection fraction (EF) and exercise capacity were determined at baseline and in 2 and 6 months of treatment. Safety of the treatments was also assessed.<br />Results. Group 1: the average CHF class (NYHA) decreased by 20.7% (p&lt;0.01), EF increased by 18.2% (p&lt;0.05). Group 2: the average CHF class decreased by 29.6% (p&lt;0.01), EF increased by 18.2% (p&lt;0.05). Group 3: the average CHF class decreased by 14.3% (p&lt;0.01), EF increased by 19.6% (p&lt;0.05). Group 4: the average CHF class decreased by 41.4% (p&lt;0.001), EF increased by 32.8% (p&lt;0.001).<br />Conclusion. Monotherapy with carvedilol in patients with ACMP was more effective than this with perindopril. Long-term monotherapy with perindopril or carvedilol in patients with DCMP was well tolerated and safety.
first_indexed 2024-03-12T04:41:54Z
format Article
id doaj.art-5ed1f9121381451b934273fe4cf77c68
institution Directory Open Access Journal
issn 1819-6446
2225-3653
language English
last_indexed 2024-03-12T04:41:54Z
publishDate 2015-09-01
publisher Столичная издательская компания
record_format Article
series Рациональная фармакотерапия в кардиологии
spelling doaj.art-5ed1f9121381451b934273fe4cf77c682023-09-03T09:33:47ZengСтоличная издательская компанияРациональная фармакотерапия в кардиологии1819-64462225-36532015-09-019663363910.1234/1819-6446-2013-6-633-639271COMPARATIVE EFFICACY OF CHRONIC HEART FAILURE TREATMENT WITH PERINDOPRIL OR CARVEDILOL IN PATIENTS WITH ALCOHOLIC OR IDIOPATHIC DILATED CARDIOMYOPATHYI. V. Zhirov0G. K. Sarbalinova1S. N. Tereschenko2Российский кардиологический научно-производственный комплекс, МоскваОбластная больница, Республика Казахстан, Западно-Казахстанская область, УральскРоссийский кардиологический научно-производственный комплекс, МоскваAim. To study the clinical and hemodynamic efficacy of monotherapy with ACE inhibitor perindopril or beta-blocker carvedilol in patients with chronic heart failure (CHF) due to dilated cardiomyopathy (DCMP) of various etiology.<br />Material and methods. Patients (n=69) with DCMP of different etiology were included into the open randomized study. Idiopathic DCMP (IDCMP) was diagnosed in 26 patients and alcoholic cardiomyopathy (ACMP) - in 43 patients. Patients of IDCMP and ACMP groups were randomized for treatment with perindopril (groups 1 and 3, respectively) or carvedilol (groups 2 and 4, respectively). Follow-up was 6 months. End-diastolic and end-systolic left ventricular volume, stroke volume index, ejection fraction (EF) and exercise capacity were determined at baseline and in 2 and 6 months of treatment. Safety of the treatments was also assessed.<br />Results. Group 1: the average CHF class (NYHA) decreased by 20.7% (p&lt;0.01), EF increased by 18.2% (p&lt;0.05). Group 2: the average CHF class decreased by 29.6% (p&lt;0.01), EF increased by 18.2% (p&lt;0.05). Group 3: the average CHF class decreased by 14.3% (p&lt;0.01), EF increased by 19.6% (p&lt;0.05). Group 4: the average CHF class decreased by 41.4% (p&lt;0.001), EF increased by 32.8% (p&lt;0.001).<br />Conclusion. Monotherapy with carvedilol in patients with ACMP was more effective than this with perindopril. Long-term monotherapy with perindopril or carvedilol in patients with DCMP was well tolerated and safety.http://www.rpcardio.ru/jour/article/view/271дилатационная кардиомиопатияхроническое злоупотребление алкоголемхроническая сердечная недостаточностькарведилолпериндоприлновая стратегия снижения потребления алкоголяналмефен
spellingShingle I. V. Zhirov
G. K. Sarbalinova
S. N. Tereschenko
COMPARATIVE EFFICACY OF CHRONIC HEART FAILURE TREATMENT WITH PERINDOPRIL OR CARVEDILOL IN PATIENTS WITH ALCOHOLIC OR IDIOPATHIC DILATED CARDIOMYOPATHY
Рациональная фармакотерапия в кардиологии
дилатационная кардиомиопатия
хроническое злоупотребление алкоголем
хроническая сердечная недостаточность
карведилол
периндоприл
новая стратегия снижения потребления алкоголя
налмефен
title COMPARATIVE EFFICACY OF CHRONIC HEART FAILURE TREATMENT WITH PERINDOPRIL OR CARVEDILOL IN PATIENTS WITH ALCOHOLIC OR IDIOPATHIC DILATED CARDIOMYOPATHY
title_full COMPARATIVE EFFICACY OF CHRONIC HEART FAILURE TREATMENT WITH PERINDOPRIL OR CARVEDILOL IN PATIENTS WITH ALCOHOLIC OR IDIOPATHIC DILATED CARDIOMYOPATHY
title_fullStr COMPARATIVE EFFICACY OF CHRONIC HEART FAILURE TREATMENT WITH PERINDOPRIL OR CARVEDILOL IN PATIENTS WITH ALCOHOLIC OR IDIOPATHIC DILATED CARDIOMYOPATHY
title_full_unstemmed COMPARATIVE EFFICACY OF CHRONIC HEART FAILURE TREATMENT WITH PERINDOPRIL OR CARVEDILOL IN PATIENTS WITH ALCOHOLIC OR IDIOPATHIC DILATED CARDIOMYOPATHY
title_short COMPARATIVE EFFICACY OF CHRONIC HEART FAILURE TREATMENT WITH PERINDOPRIL OR CARVEDILOL IN PATIENTS WITH ALCOHOLIC OR IDIOPATHIC DILATED CARDIOMYOPATHY
title_sort comparative efficacy of chronic heart failure treatment with perindopril or carvedilol in patients with alcoholic or idiopathic dilated cardiomyopathy
topic дилатационная кардиомиопатия
хроническое злоупотребление алкоголем
хроническая сердечная недостаточность
карведилол
периндоприл
новая стратегия снижения потребления алкоголя
налмефен
url http://www.rpcardio.ru/jour/article/view/271
work_keys_str_mv AT ivzhirov comparativeefficacyofchronicheartfailuretreatmentwithperindoprilorcarvedilolinpatientswithalcoholicoridiopathicdilatedcardiomyopathy
AT gksarbalinova comparativeefficacyofchronicheartfailuretreatmentwithperindoprilorcarvedilolinpatientswithalcoholicoridiopathicdilatedcardiomyopathy
AT sntereschenko comparativeefficacyofchronicheartfailuretreatmentwithperindoprilorcarvedilolinpatientswithalcoholicoridiopathicdilatedcardiomyopathy